Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIR
查看詳細走勢圖
0.140USD
-0.010-6.47%
收盤 12/10, 16:00（美東）報價延遲15分鐘
--總市值
--本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-6.47%
5天
0.00%
1月
0.00%
6月
0.00%
今年開始到現在
0.00%
1年
0.00%
查看詳細走勢圖
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030簡介
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
公司代碼DMIIR
公司Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
CEOStockwell (Lynn)
網址
常見問題
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的當前股價是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的當前股價是 0.140。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 的股票代碼是什麼？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的股票代碼是DMIIR。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52週最高點是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52週最高點是0.170。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52週最低點是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52週最低點是0.140。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的市值是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的市值是--。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的淨利潤是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的淨利潤為--。
現在Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的股票是買入、持有還是賣出？
根據分析師評級，Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的總體評級為--，目標價格為--。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)股票的每股收益（EPS TTM）是多少
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)股票的每股收益（EPS TTM）是--。
